For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Exceptional circumstances pathway recognises uniqueness of patients
+Print Archive
How it works
Exceptional circumstances pathway recognises uniqueness of patients
Wednesday 6 November 2024, 12:00 AM

Pharmac’s exceptional circumstances framework can help a person with exceptional clinical needs get a medicine they can’t access through the pharmaceutical schedule [Image: Anunay Rai on Unsplash]
Adrienne Martin explains Pharmac’s exceptional circumstances framework, outlining how it connects with the national funding process and how clinicians submit applications on behalf of patients
As clinicians, all people you treat are unique, and sometimes people are so unique that usual funding mechanisms for medicines don’t quite fit for the
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.